Our Commitment

With cell and gene therapy development on the rise, quality control (QC) microbiology labs must evolve to handle more complex processes, unique scale-up needs, and reduced “vein-to-vein” timelines. These therapies require rapid and precise microbial testing to ensure patient safety and regulatory compliance.

At the same time, the demanding requirements for lot release add another layer of complexity. To safely deliver these time-sensitive treatments, QC labs must adopt solutions that streamline workflows, reduce manual interventions, and enhance data integrity.

Fortunately, careful planning and advanced technologies can open the door to productive and safe scale-up manufacturing. Discover how our automation technology can enable the safe, rapid release of your critical therapies.